Comparing ultrasonic nebulization with lignocaine and USG guided upper airway blocks for awake fiberoptic intubation in head and neck cancer surgery.

Randomized control trial comparing ultrasonic nebulization with lignocaine and USG guided upper airway blocks for awake fiberoptic intubation in head and neck cancer surgery. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092865

Enrollment

Registered

2025-08-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: lignocaine: Ultrasonic nebulization with 5ml 4% lignocaine will be given before fibre optic intubation Control Intervention1: USG guided airway block: Before intubation superior larynge

Eligibility

Inclusion criteria

Inclusion criteria: Patient with head and neck cancer Age 18-65yrs Both male and female ASA 1-3 Anticipated Difficult airway

Exclusion criteria

Exclusion criteria: Patient refused to participate Hemodynamically unstable pts Large swelling infront of neck or obstructing larynx With coagulopathy Cardiac conduction defect Psychiatry disorder H/O allergy to study drug

Design outcomes

Primary

Measure	Time frame
To observe the effectiveness of nebulization by cough, gag,and comfort scoreTimepoint: during intubation	—

Secondary

Measure	Time frame
Success in intubation at 1st attemptTimepoint: 1st attempt;Time taken for intubationTimepoint: Just after nebulization till securing the tube;Post procedural complicationsTimepoint: Till case finishes	—

Countries

India

Contacts

Public ContactNishu Kumari

Acharyharihar Postgraduate institute of Cancer Cuttack

rekhadas2003@yahoo.co.in9437016520

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026